ADIPOCYTOKINES AS PATHOGENIC MEDIATORS AND THERAPEUTIC TARGETS IN METABOLIC SYNDROME-RELATED CARDIOCEREBROVASCULAR EVENTS

Descargar Publicación
CBL-514: el fármaco experimental que elimina adipocitos Endocrine Disruptors, Gut Microbiota, and Type 2 Diabetes: Bridging Mechanisms to Probiotic-Based Therapeutic Approaches